These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37910780)
1. The role of m6A RNA methylation regulator in meningioma. Yang Y; Luo L; Zhou Z Aging (Albany NY); 2023 Oct; 15(21):12068-12084. PubMed ID: 37910780 [TBL] [Abstract][Full Text] [Related]
2. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6. Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831 [TBL] [Abstract][Full Text] [Related]
3. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators. Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327 [TBL] [Abstract][Full Text] [Related]
4. The m6A methylation profiles of immune cells in type 1 diabetes mellitus. Wang Y; Xu L; Luo S; Sun X; Li J; Pang H; Zhou J; Zhou Y; Shi X; Li X; Huang G; Xie Z; Zhou Z Front Immunol; 2022; 13():1030728. PubMed ID: 36457997 [TBL] [Abstract][Full Text] [Related]
5. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
6. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis. Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782 [TBL] [Abstract][Full Text] [Related]
8. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value. Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253 [TBL] [Abstract][Full Text] [Related]
11. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834 [No Abstract] [Full Text] [Related]
12. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7). Wei K; Gao Y; Wang B; Qu YX Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522 [TBL] [Abstract][Full Text] [Related]
13. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
14. m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease. Huang X; Lv D; Yang X; Li M; Zhang H J Cell Mol Med; 2020 Nov; 24(21):12706-12715. PubMed ID: 32961012 [TBL] [Abstract][Full Text] [Related]
15. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma. Hu Y; Chen J; Liu M; Feng Q; Peng H Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
18. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731 [TBL] [Abstract][Full Text] [Related]
19. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Sun Z; Jing C; Xiao C; Li T; Wang Y Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247 [TBL] [Abstract][Full Text] [Related]
20. The Cancer Genome Atlas (TCGA) based m6A methylation-related genes predict prognosis in rectosigmoid cancer. Zhou W; Lin J; Li Z; Li M; Fan D; Hong L Medicine (Baltimore); 2022 Dec; 101(51):e32328. PubMed ID: 36595765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]